Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001204
Filing Date
2025-05-13
Accepted
2025-05-13 06:51:44
Documents
57
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20250331x10q.htm   iXBRL 10-Q 1003810
2 EX-31.1 lptx-20250331xex31d1.htm EX-31.1 12473
3 EX-32.1 lptx-20250331xex32d1.htm EX-32.1 7291
  Complete submission text file 0001410578-25-001204.txt   4812442

Data Files

Seq Description Document Type Size
4 EX-101.SCH lptx-20250331.xsd EX-101.SCH 37993
5 EX-101.CAL lptx-20250331_cal.xml EX-101.CAL 30470
6 EX-101.DEF lptx-20250331_def.xml EX-101.DEF 140574
7 EX-101.LAB lptx-20250331_lab.xml EX-101.LAB 358593
8 EX-101.PRE lptx-20250331_pre.xml EX-101.PRE 243835
60 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20250331x10q_htm.xml XML 714110
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 25937062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)